Although some studies suggest that patterns of cognitive changes associated with AD-genetic risk profiles might be observed early in life, others argue for a broader perspective, suggesting that cognitive function is not significantly affected in healthy APOE ε4 carriers [25–27]. Here, APOE is linked to Alzheimer disease.